IMMUTEP Ltd SEC filings PRRUF
IMMUTEP Ltd has 739 filings in SEC EDGAR's recent list, going back to Feb 13, 2012. Its latest annual report, Form 20-F, was filed on Oct 23, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 2, 2026. The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| F-3 | Shelf registration (foreign issuer) | Apr 28, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 15, 2019 | — |
| 424B3 | Prospectus | Feb 14, 2019 | — |
| F-3 | Shelf registration (foreign issuer) | Jan 14, 2019 | — |
| 424B5 | Prospectus supplement | Dec 19, 2018 | — |
| F-3 | Shelf registration (foreign issuer) | Oct 19, 2017 | — |
| 424B5 | Prospectus supplement | Jun 30, 2017 | — |
| 424B5 | Prospectus supplement | Jun 29, 2017 | — |
| F-3 | Shelf registration (foreign issuer) | May 27, 2016 | — |
| F-3 | Shelf registration (foreign issuer) | Aug 28, 2013 | — |
| F-6 | Form f-6 | Apr 3, 2012 | — |
Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- IMMP (Nasdaq), PRRUF (OTC)
- Fiscal year ends
- June 30
- Incorporated in
- Australia
- Headquarters
- Sydney,, Australia
- SEC filer status
- Accelerated filer
- SEC CIK
- 1506184
- Former names
- Prima BioMed Ltd (until Dec 1, 2017)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.